» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-25 of 735 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
and treatment of COVID-19 patients in Bojnurd Design: Shuffle block randomization Triple blinding (...) exclusion criteria: inclusion criteria Prophylactic study: Those who live with a Covid-19 patient in a single house. Have not had Covid-19 (or its symptoms) so far. Maximum 7 days have passed since start of
IRCTID: IRCT20150902023864N2
Study aim: Evaluation of early outcomes of liver transplantation from COVID-19 positive deceased donors and risk of transmission of COVID-19 in liver transplant Design: Non-randomized non-inferiority (...) hospital (COVID-19 center), in accordance with all health protocols, and the harvested liver will be
IRCTID: IRCT20200928048867N1
patients with COVID-19 2. Detection effect of Montelukast on duration of hospitalization, changes of (...) will give standard treatment of COVID-19 disease but test group will take Montelukast (Airokast, Abidi (...) exclusion criteria: Inclusion criteria: 1-All hospitalized patients with confirmed COVID-19 at both gender
IRCTID: IRCT20180624040213N2
from Covid-19 in improving clinical and laboratory symptoms of hospitalized patients Design: The (...) will be performed at Kosar hospital in Semnan. Convalescent plasma from COVID-19 recovered people will be injected to hospitalized patients suffering from COVID-19. Participants/Inclusion and exclusion
IRCTID: IRCT20151228025732N53
Study aim: Effect of Thalidomide on moderate COVID-19 pneumonia Design: Clinical trial with (...) performed in Taleghani Hospital in Tehran on patients with moderate pneumonia caused by Covid-19. Patients (...) laboratory results based on Covid-19, radiographic results indicating the presence of injury and lung
IRCTID: IRCT20210614051574N5
Study aim: Evaluating the efficacy of methylprednisolone mini pulse therapy on COVID-19 patients (...) which will be carried out on 60 hospitalized ‎COVID-19 patients. Settings and conduct: This clinical trial will be carried out on 60 hospitalized COVID-19 patients in Intensive care unit of imam Khomeini
IRCTID: IRCT20170716035126N4
Study aim: Determination of the effectiveness of Cyclotide complex in the prevention of COVID-19 virus after exposure to patients with COVID-19 and comparison with the control group Design: This (...) healthy individuals in exposure to a patient with COVID-19. Randomization will be by block randomization
IRCTID: IRCT20160131026298N4
in treatment of Covid-19 patients with ARDS Design: This study is a two arm parallel group, randomized clinical trial in phase 2 which will be carried out on 40 hospitalized ‎COVID-19 patients (...) on 40 hospitalized COVID-19 patients in Intensive care unit of imam Reza hospital of AJA university
IRCTID: IRCT20200406046963N2
positive test for COVID-19 virus Design: This study is a double blind clinical trial which has two (...) nominated by a code will be gave to the patients and after 5 days the COVID-19 RtPCR will be done on the (...) . Participants/Inclusion and exclusion criteria: Every patient with positive COVID-19 PCR and positive regard for
IRCTID: IRCT20181208041886N2
with COVID-19 in Bu Ali Sina Hospital in Qazvin in 2021 Design: A double-blind randomized clinical (...) used for randomization. Settings and conduct: The study population is patients with COVID-19 admitted to Bouali sina Hospital in Qazvin in 2021 who has developed COVID-19 pneumonia and pulmonary
IRCTID: IRCT20210710051831N1
with COVID-19 Design: The randomized clinical trial, parallel groups, 200 patients will be enrolled (...) will be prescribed standard regimen for COVID-19. Patients in Metformin group will be prescribed Metformin 500 mg BID for two weeks and standard regimen for COVID-19. The routine lab data, hospitalization
IRCTID: IRCT20160310026998N11
Study aim: Evaluation the efficacy and safety of Hydroxychloroquine administration for COVID-19 (...) over 18 years old and had a close contact with a COVID-19 case at least in past 4 days and signed the informed consent form included. Also, pervious cases of COVID-19 and who had flu like symptoms or those
IRCTID: IRCT20130917014693N10
  1. A Randomized, Multi-centric, Double-blind, Placebo-controlled study to Evaluate the Efficacy and Safety of Bromhexine, a serine protease (TMPRSS2) blocker, to prevent COVID-19
  2. Evaluation the efficacy and safety of Umifenovir (Arbidol) Administration in comparison with Lopinavir-ritonavir (Kaletra) in COVID-19 patients
  3. Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers
  4. Evaluation of the efficacy and safety of oral pentoxifylline in treatment and recovery of patients with COVID-19 admitted in Rasoul Akram and firoozgar hospitals treated with routine protocols, A randomized controlled clinical trial
  5. Evaluation of the efficacy and safety of Umifenovir in the treatment of hospitalized patients with covid-19: A randomized clinical trial
  6. Evaluation the efficacy and safety of Sitagliptin administration in patients with COVID-19
  7. Safety evaluation of a quadrivalent recombinant influenza vaccine (serotypes of 2021/2022) manufactured by Nivad Pharmed Salamat, open label, single arm, in volunteers aged ≥ 18 years.
  8. Evaluating effectiveness and safety of Umifenovir in the treatment (COVID-19)infection In patients referred to Tehran Imam Khomeini Hospital Complex
  9. Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19
  10. Evaluation the efficacy and safety of Favipiravir made by Shahid Beheshti University of Medical Sciences in comparison with Lopinavir-ritonavir in COVID-19 patients
which will be carried out on 40 hospitalized ‎COVID-19 patients. Patients randomly divided into two groups. Settings and conduct: This clinical trial will be carried out on 40 hospitalized COVID-19 (...) criteria: Inclusion Criteria: Patients admitted to ICU with moderate to severe Covid-19 infection needs
IRCTID: IRCT20200406046963N1
Study aim: Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial (...) COVID-19 pneumonia based on PCR or pulmonary imaging; Presenting clinical symptoms of COVID-19 (fever
IRCTID: IRCT20201004048922N1
patients with COVID-19 Design: The randomized clinical trial with a parallel group design in which 200 (...) standard regimen for COVID-19. Patients in Metformin group will be prescribed Metformin 500 mg BID for two weeks and standard regimen for COVID-19. The routine lab data, need for hospitalization and mortality
IRCTID: IRCT20160310026998N10
Lopinavir-ritonavir in COVID-19 patients Design: Clinical trial with parallel randomized groups Settings (...) study, patients who were between 18 and 100 years old, confirmed COVID-19 with RT-PCR, and signed the (...) liver disease, mild cases of COVID-19 (outpatients) or critical cases of COVID-19 (needs to ICU or
IRCTID: IRCT20151227025726N15
Study aim: Reduce the infection with covid-19 and mortality of staff due to covid-19 with favipiravir treatment during the Covid- 19 epidemic. Design: Thirty people in the intensive care unit who (...) . Settings and conduct: Thirty ICU staff who are in direct contact with Covid-19 positive patients have been
IRCTID: IRCT20150107020592N30
patients with respiratory failure caused by the COVID-19 Design: Clinical trial with one intervention group, with no control group and no blindness on 40 hospitalized patients with severe forms of COVID-19 (...) patients with severe forms of COVID-19. Inclusion Criteria: Patients with diagnosis of COVID-19 based on
IRCTID: IRCT20200608047686N2
Study aim: Evaluating the IL-6 level in COVID-19 patients hospitalized in Intensive Care Unit (ICU), after consuming Fluvoxamine. Comparing the IL-6 level in two groups of COVID-19 patients, hospitalized (...) Massih Daneshvari Hospital, which 40 hospitalized patients in ICU ward due to COVID-19 are selected by
IRCTID: IRCT20131115015405N4
Study aim: Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patients to provide a safe and low-cost way to cure or lowering the consequences of COVID-19 Design: Phase (...) : Inclusion: Healthy individuals exposed directly and constantly with COVID-19 patients. COVID-19 patients who
IRCTID: IRCT20200408046987N3
COVID-19 Design: Clinical trial with controlled group, parallel design, double-blinded, multi-centric (...) informed consent; Age of 18 years or more; Exposure and close contact with a COVID-19 patients within 4 (...) for prophylaxis or treatment if COVID-19; patients with any sign and symptoms of COVID-19
IRCTID: IRCT20120703010178N22
management of COVID-19. Design: This is a single arm, with no control group, not blinded and randomized (...) symptoms and signs who are admitted in ICU) complications of COVID-19, will receive septimeb (infusion) for (...) years Known case of Covid-19 by relative signs, symptoms, Lab., radiology and CT scan Data. Existence
IRCTID: IRCT20200324046847N1
psychological symptoms associated with Covid-19 pandemic in individuals with a history of Covid-19 infection or (...) Kermanshah, questionnaires (GAD-7,Coronavirus Anxiety Scale ,OCS ,COVID-19-PTSD and sleep quality) will be (...) criteria: People who became infected with the virus themselves or a family member during the Covid-19
IRCTID: IRCT20180312039056N4
  1. Developing a Mindful Self-compassion Training Program with Focus on Life style and Evaluating Effectiveness on Early Maladaptive Schemas, Quality of Life, and Family Functioning of Mothers of Children with Autism Spectrum Disorder
  2. The Effectiveness of the Mindful Self-Compassion Therapy on Psychological Symptoms of Cardiovascular Diseases
  3. Efficacy and safety of "BioBoost" supplement on the incidence of COVID-19 symptoms of asymptomatic family members of COVID-19 patients: A Randomized cluster clinical trial, parallel, Phase 3, doubled blinded and placebo controlled
  4. Evaluation of slow release mucoadhesive paste of” Mucodentol “ on symptoms of COVID-19 disease in non infected family members of infected patients by COVID-19
  5. Comparison the Effectiveness of Child Mindfulness Therapy, Mindful Parenting and Combination Therapy of These Two Interventions in Attention Deficit / Hyperactivity Disorder: A Outcome-Based Study
  6. Favipiravir prophylactic to reduce the involvement of health care workers in the COVID-19 epidemic
  7. The Effect of Tele-Nursing on Caregiver Burden in Family Caregivers and Self-Efficacy in Patients With Covid-19 After Discharge From Hospitals
  8. The Effectiveness of Integrative Treatment Interventions on Covid-19 Patients: A Clinical Trial Based Evaluation
  9. The effect of the Video communication between patient and family member on hospital anxiety and depression of of affected patients with COVID-19 and perceived stress of family member
  10. Comparison of the effectiveness of compassion-based emotion-focused combination therapy package with compassion-based therapy on quality of life in patients with primary headache symptoms
pneumonia in patients with moderate to severe COVID-19 Design: Clinical trial with control group, parallel (...) randomized clinical trial will be performed on patients with COVID-19 admitted to Mazandaran teaching (...) /Inclusion and exclusion criteria: Inclusion: Children and adults with moderate to severe COVID-19 Having one
IRCTID: IRCT20111224008507N6
with Coronavirus disease (COVID-19) Design: Clinical trial, no control group, no randomization, phase (...) patients with a diagnosis of Covid-19 disease admitted to the intensive care unit of Hazrat Rasoul Akram (...) /Inclusion and exclusion criteria: Coronavirus disease (COVID-19) admitted in the intensive care unit (ICU
IRCTID: IRCT20180316039112N3
Loading...